Adjuvant nivolumab versus ipilimumab (CheckMate 238 trial): Reassessment of 4-year efficacy outcomes in patients with stage III melanoma per AJCC-8 staging criteria
Resource Type
Article
Authors
Larkin, James ; Weber, Jeffrey ; Del Vecchio, Michele ; Gogas, Helen ; Arance, Ana M. ; Dalle, Stephane ; Cowey, C. Lance ; Schenker, Michael ; Grob, Jean-Jacques ; Chiarion-Sileni, Vanna ; Márquez-Rodas, Iván ; Butler, Marcus O. ; Di Giacomo, Anna Marie ; Middleton, Mark R. ; De la Cruz-Merino, Luis ; Arenberger, Petr ; Atkinson, Victoria ; Hill, Andrew ; Fecher, Leslie A. ; Millward, Michael ; Khushalani, Nikhil I. ; Queirolo, Paola ; Long, Georgina V. ; Lobo, Maurice ; Askelson, Margarita ; Ascierto, Paolo A. ; Mandalá, Mario
Source
In European Journal of Cancer September 2022 173:285-296
Subject
Language
ISSN
0959-8049